Document Detail


Inflammation and adverse cardiovascular outcome in patients with renal artery stenosis and peripheral artery disease.
MedLine Citation:
PMID:  19152915     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: We hypothesized that high sensitivity C-reactive protein (hs-CRP) and the presence of renal artery stenosis (RAS) might conjointly predict future major adverse cardiovascular events (MACE) in patients with peripheral artery disease (PAD). BACKGROUND: Clinical outcome in PAD is determined by the extent of atherosclerosis affecting additional vascular beds and the activity of the atherosclerotic process reflected by inflammatory serum markers. Data on the predictive value of hs-CRP on outcome in PAD patients with RAS is limited. METHODS: We prospectively enrolled 447 PAD patients who were admitted to our institution for angioplasty. Preintervention hs-CRP was assessed and renal angiograms were obtained. Patients were then followed clinically for the occurrence of MACE for median 15.6 months. Serum creatinine was obtained in all patients at 12 months. RESULTS: Incidental RAS >or=60% at baseline was found in 68 patients (15.2%), MACE were recorded in 111 patients during follow-up. Hs-CRP was significantly associated with the occurrence of MACE (p<0.001) and with 12 months creatinine levels (p=0.005). Adjusted hazard ratios for MACE for increasing quartiles of hs-CRP as compared to the lowest quartile were 1.11 (95% CI 0.53-2.35), 1.06 (95% CI 0.50-2.26) and 2.79 (95% CI 1.47-5.28). Analyzing joint effects of hs-CRP and RAS, we observed no significant interaction. CONCLUSION: Hs-CRP predicts cardiovascular and renal outcome in PAD patients irrespective of the presence of RAS. Patients with hs-CRP levels above 0.88 mg/dL were at particularly high risk for MACE.
Authors:
Oliver Schlager; Jasmin Amighi; Markus Haumer; Schila Sabeti; Petra Dick; Wolfgang Mlekusch; Christian Loewe; Renate Koppensteiner; Erich Minar; Martin Schillinger
Related Documents :
7850255 - Relationship between leukotriene b4 and prostaglandin i2 in patients with sepsis.
20213025 - Evaluation of serum levels of c-reactive protein and lipid profiles in patients with ch...
3343665 - Use of c-reactive protein to predict the outcome of medical management of tuboovarian a...
11791805 - C-reactive protein and paroxysmal atrial fibrillation: evidence of the implication of a...
8295175 - Levels of urinary polyamines in patients with rheumatoid arthritis.
10389285 - Pseudomonas aeruginosa central nervous system infections: analysis of clinical features...
Publication Detail:
Type:  Journal Article     Date:  2008-12-24
Journal Detail:
Title:  Atherosclerosis     Volume:  205     ISSN:  1879-1484     ISO Abbreviation:  Atherosclerosis     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-22     Completed Date:  2009-08-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0242543     Medline TA:  Atherosclerosis     Country:  Ireland    
Other Details:
Languages:  eng     Pagination:  314-8     Citation Subset:  IM    
Affiliation:
Department of Angiology, Medical University Vienna, Vienna, Austria. oliver.schlager@meduniwien.ac.at
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Angioplasty
C-Reactive Protein / biosynthesis
Cardiovascular Diseases / complications*,  diagnosis*
Creatinine / blood
Female
Humans
Inflammation
Male
Middle Aged
Peripheral Vascular Diseases / complications*,  diagnosis*
Prospective Studies
Renal Artery Obstruction / complications*,  diagnosis*
Treatment Outcome
Chemical
Reg. No./Substance:
60-27-5/Creatinine; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study.
Next Document:  The up-regulation of monocyte chemoattractant protein-1 (MCP-1) in Ea.hy 926 endothelial cells under...